Product Spotlight: Aniara Diagnostica would like to announce the availability of Buffered Sodium Citrate 3.2% (0.109 M)
Aniara Diagnostica is pleased to announce the availability of Buffered Sodium Citrate 3.2%, a general anti-coagulant agent used in laboratory examinations.
WEST CHESTER, Ohio, May 27, 2021 /PRNewswire-PRWeb/ -- Aniara Diagnostica, a multi-national distributor of diagnostic and research agents, as well as screening tools, has strengthened its commitment to meeting today's highest standards for product quality and cost-efficient delivery.
For Research Use Only. Not for Use in Diagnostic Procedures.
Buffered Sodium Citrate is used in clinical laboratories, venous blood collection tubes and in blood banks as an effective anti-coagulant, usually in a ratio of 1:9 sodium citrate/blood. The citrate ion chelates calcium ions in the blood by forming calcium citrate complexes and disrupting the blood clotting mechanism.
A12-8480-10 Buffered Sodium Citrate 3.2% (0.109 M) (100 mL) (10 pouches) click here for more information
A12-8483-5 Buffered Sodium Citrate 3.2% (0.109 M) (1000mL) (5 pouches) click here for more information
The entire Aniara product line is available for purchase at http://www.aniara.com. The Company distributes products in North America, Central America, South America, Sweden, Norway, Denmark, Finland, Lithuania, Latvia, Estonia and Iceland.
Media Contact
Maria Waldron, Aniara Diagnostica, 5133423018, [email protected]
SOURCE Aniara Diagnostica
Share this article